Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction

Molecular and Cellular Endocrinology

Volumn 350, Issue 1, 2012, Pages 61-71

  Wallacides, Angelina ^a   Chesnel, Amand ^a   Ajj, Hussein ^a   Chillet, Martine ^a   Flament, Stéphane ^a   Dumond, Héène ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

ER 36; Estrogens; Proliferation; Seminoma; TCam 2

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 36; G PROTEIN COUPLED RECEPTOR; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ESTROGEN ACTIVITY; HORMONE ACTION; HORMONE RESPONSE; IMMUNOCYTOCHEMISTRY; MICROFILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEMINOMA; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MALE; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SEMINOMA; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84856034184     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.11.021     Document Type: Article

References (57)

1. Almstrup K., Ottesen A.M., Sonne S.B., Hoei-Hansen C.E., Leffers H., Rajpert-De Meyts E., Skakkebaek N.E. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell. Tissue. Res. 2005, 322:159-165.
2. Bouskine A., Nebout M., Brücker-Davis F., Benahmed M., Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ. Health. Perspect. 2009, 117:1053-1058.
3. Bouskine A., Nebout M., Mograbi B., Brücker-Davis F., Roger C., Fenichel P. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. Endocrinology 2008, 149:565-573.
4. Bouskine A., Vega A., Nebout M., Benahmed M., Fénichel P. Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma. Int. J. Androl. 2010, 33:54-63.
5. Carreau S., Hess R.A. Oestrogens and spermatogenesis. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2010, 365:1517-1535.
6. Carreau S., Wolczynski S., Galeraud-Denis I. Aromatase, oestrogens and human male reproduction. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2010, 365:1571-1579.
7. Chevalier, N., Bouskine, A., Fenichel, P., 2011 Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int. J. Cancer. doi: 10.1002/ijc.25972.
8. Chevalier N., Bouskine A., Fenichel P. Role of GPER/GPR30 in tumoral testicular germ cells proliferation. Cancer Biol. Ther. 2011, 12(1):2-3.
9. Cools M., Looijenga L.H., Wolffenbuttel K.P., Drop S.L. Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. World J. Pediatr. 2009, 5(2):93-102.
10. Cools M., Wolffenbuttel K.P., Drop S.L., Oosterhuis J.W., Looijenga L.H. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev. 2011, 5(4):167-180.
11. de Jong J., Stoop H., Gillis A.J.M., Hersmus R., van Gurp R.J.H.L.M., van de Geijn G.-J.M., van Drunen E., Beverloo H.B., Schneider D.T., Sherlock J.K., Baeten J., Kitazawa S., van Zoelen E.J., van Roozendaa K., Oosterhuis J.W., Looijenga L.H.J. Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 2008, 47:185-196.
12. Delbès G., Levacher C., Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction 2006, 132:527-538.
13. Dennis M.K., Burai R., Ramesh C., Petrie W.K., Alcon S.N., Nayak T.K., Bologa C.G., Leitao A., Brailoiu E., Deliu E., Dun N.J., Sklar L.A., Hathaway H.J., Arterburn J.B., Oprea T.I., Prossnitz E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5:421-427.
14. Eckert D., Nettersheim D., Heukamp L.C., Kitazawa S., Biermann K., Schorle H. TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell. Tissue. Res. 2008, 331:529-538.
15. Filardo E.J. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid. Biochem. Mol. Biol. 2002, 80:231-238.
16. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
17. Flamini M.I., Sanchez A.M., Genazzani A.R., Simoncini T. Estrogen regulates endometrial cell cytoskeletal remodeling and motility via focal adhesion kinase. Fertil. Steril. 2011, 95:722-726.
18. Franco, R., Boscia, F., Gigantino, V., Marra, L., Esposito, F., Ferrara, D., Pariante, P., Botti, G., Caraglia, M., Minucci, S., Chieffi, P., 2011. GPR30 is over-expressed in post puberal testicular germ cell tumors. Cancer Biol. Ther. 15, 11(6).
19. Giretti M.S., Fu X., De Rosa G., Sarotto I., Baldacci C., Garibaldi S., Mannella P., Biglia N., Sismondi P., Genazzani A.R., Simoncini T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS ONE 2008, 3:e2238. 10.1371/journal.pone.0002238.
20. Jones M.E.E., Boon W.C., Proietto J., Simpson E.R. Of mice and men: the evolving phenotype of aromatase deficiency. Trends. Endocrinol. Metab. 2006, 17:55-64.
21. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., Wang Z. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 2010, 24:709-721.
22. Kristensen D.M., Sonne S.B., Ottesen A.M., Perrett R.M., Nielsen J.E., Almstrup K., Skakkebaek N.E., Leffers H., Rajpert-De Meyts E. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Mol. Cell Endocrinol. 2008, 288(1-2):111-118.
23. Lee L.M.J., Cao J., Deng H., Chen P., Gatalica Z., Wang Z. ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer. Res. 2008, 28:479-483.
24. Lin S.L., Yan L., Liang X.W., Wang Z.B., Wang Z.Y., Qiao J., Schatten H., Sun Q.Y. A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Reprod. Biol. Endocrinol. 2009, 7:102.
25. Lin, S.L., Yan, L.Y., Zhang, X.T., Yuan, J., Li, M., Qiao, J., Wang, Z.Y., Sun, Q.Y., 2010. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. PLoS One, 2010 February 2, 5(2):e9013. doi:10.1371/journal.pone.0009013.
26. Looijenga, L.H., Gillis, A.J., Stoop, H., Biermann, K., Oosterhuis, J.W., 2011. Dissecting the molecular pathways of (testicular) germ cell tumor pathogenesis; from initiation to treatment-resistance. Int. J. Androl. 34(4 Pt. 2), e234-e251.
27. Maggiolini M., Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J. Endocrinol. 2010, 204:105-114.
28. Main K.M., Skakkebaek N.E., Virtanen H.E., Toppari J. Genital anomalies in boys and the environment. Best. Pract. Res. Clin. Endocrinol. Metab. 2010, 24:279-289.
29. Marcias G., Erdmann E., Lapouge G., Siebert C., Barthélémy P., Duclos B., Bergerat J., Céraline J., Kurtz J. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell. Line. Hum. Mutat. 2010, 31:74-80.
30. Martin O.V., Shialis T., Lester J.N., Scrimshaw M.D., Boobis A.R., Voulvoulis N. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ. Health. Perspect. 2008, 116:149-157.
31. McIntyre A., Gilbert D., Goddard N., Looijenga L.H., Shipley J. Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults. Genes. Chromosomes. Cancer 2008, 47:547-557.
32. McIntyre A., Summersgill B., Lu Y.J., Missiaglia E., Kitazawa S., Oosterhuis J.W., Looijenga L.H., Shipley J. Genomic copy number and expression patterns in testicular germ cell tumors. Br. J. Cancer 2007, 97:1707-1712.
33. Mizuno Y., Gotoh A., Kamidono S., Kitazawa S. Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2). Nippon. Hinyokika. Gakkai. Zasshi. 1993, 84:1211-1218.
34. Murata Y., Robertson K.M., Jones M.E.E., Simpson E.R. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol. Cell. Endocrinol. 2002, 193:7-12.
35. O'Donnell L., Robertson K.M., Jones M.E., Simpson E.R. Estrogen and spermatogenesis. Endocr. Rev. 2001, 22:289-318.
36. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28:523-532.
37. Pentikäinen V., Erkkilä K., Suomalainen L., Parvinen M., Dunkel L. Estradiol acts as a germ cell survival factor in the human testis in vitro. J. Clin. Endocrinol. Metab. 2000, 85:2057-2067.
38. Pleskacova J., Hersmus R., Oosterhuis J.W., Setyawati B.A., Faradz S.M., Cools M., Wolffenbuttel K.P., Lebl J., Drop S.L., Looijenga L.H. Tumor risk in disorders of sex development. Sex Dev. 2010, 4-5:259-269.
39. Rago, V., Romeo, F., Giordano, F., Maggiolini, M., Carpino, A., 2011. Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes. Reprod. Biol. Endocrinol. 9(1), 135.
40. Rajpert-de Meyts E., Hoei-Hansen C.E. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann. NY Acad. Sci. 2007, 1120:168-180.
41. Roger C., Lambard S., Bouskine A., Mograbi B., Chevallier D., Nebout M., Pointis G., Carreau S., Fenichel P. Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase. J. Mol. Endocrinol. 2005, 35:191-199.
42. Roth M.Y., Lin K., Amory J.K., Matsumoto A.M., Anawalt B.D., Snyder C.N., Kalhorn T.F., Bremner W.J., Page S.T. Serum LH correlates highly with intratesticular steroid levels in normal men. J. Androl. 2010, 31:138-145.
43. Sanchez A.M., Flamini M.I., Baldacci C., Goglia L., Genazzani A.R., Simoncini T. Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol. Endocrinol. 2010, 24:2114-2125.
44. Sanchez, A.M., Flamini, M.I., Zullino, S., Gopal, S., Genazzani, A.R., Simoncini, T., 2010. Estrogen receptor-alpha promotes endothelial cell motility through focal adhesion kinase. Mol. Hum. Reprod. doi: 10.1093/molehr/gaq097.
45. Simoncini T., Fornari L., Mannella P., Varone G., Caruso A., Liao J.K., Genazzani A.R. Novel non-transcriptional mechanisms for estrogen receptor signalling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids 2002, 67:935-939.
46. Simoncini T., Mannella P., Fornari L., Caruso A., Varone G., Genazzani A.R. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 2004, 69:537-542.
47. Skakkebaek N.E. Possible carcinoma in situ of the testis. Lancet 1972, 2:516-517.
48. Sonne S.B., Kristensen D.M., Novotny G.W., Olesen I.A., Nielsen J.E., Skakkebaek N.E., Rajpert-De Meyts E., Leffers H. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int. J. Androl. 2008, 31(2):275-287.
49. Sonne S.B., Almstrup K., Dalgaard M., Juncker A.S., Edsgard D., Ruban L., Harrison N.J., Schwager C., Abdollahi A., Huber P.E., Brunak S., Gjerdrum L.M., Moore H.D., Andrews P.W., Skakkebaek N.E., Rajpert-De Meyts E., Leffers H. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer. Res. 2009, 69:5241-5250.
50. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
51. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
52. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 2005, 336:1023-1027.
53. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signalling. Proc. Natl. Acad. Sci. USA 2006, 103:9063-9068.
54. Wang L., Zhang X., Wang Z. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance. Anticancer. Res. 2010, 30:3637-3642.
55. Weber S., Eckert D., Nettersheim D., Gillis A.J.M., Schäfer S., Kuckenberg P., Ehlermann J., Werling U., Biermann K., Looijenga L.H.J., Schorle H. Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biol. Reprod. 2010, 82:214-223.
56. Woodfield G.W., Horan A.D., Chen Y., Weigel R.J. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signalling. Cancer Res. 2007, 67:8439-8443.
57. Zhang, X.T., Kang, L.G., Ding, L., Vranic, S., Gatalica, Z., Wang, Z., 2010. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene. doi:10.1038/onc.2010.458.